About

Mauro Citterio is a Member of the Board of Plastiape SpA (a Berry Global company), where he leads R&D and industrialisation activities. Since joining the company in 1998, Mr Citterio has had various responsibilities, including technical and economical evaluation of new business opportunities, costing and pricing, development of new design concepts, project management, equipment industrialisation and maintenance. He founded the company’s core team dedicated to regulatory compliance for medical devices. He is named as inventor or co-inventor on multiple international patents and has been an invited lecturer at various international conferences. Mr Cittero holds an MSc in Management, Economics and Industrial Engineering.

Contributions

CONNECTIVITY

RS01X – BERRY GLOBAL HEALTHCARE’S SINGLE-DOSE DPI GOES DIGITAL WITH AMIKO’S RESPIRO

Mauro Citterio, Director, Marco Franza and Martijn Grinovero discuss Berry and Amiko’s partnership to develop the RS01X connected single-dose dry powder inhaler, based on Berry’s commercialised RS01 inhaler and Amiko’s Respiro digital health platform.